EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges

Despite advances in surgery and adjuvant regimes, gastrointestinal malignancy remains a major cause of neoplastic mortality. Immunotherapy is an emerging and now successful treatment modality for numerous cancers that relies on the manipulation of the immune system and its effector functions to erad...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudry, M A, Sales, K, Ruf, P, Lindhofer, H, Winslet, M C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360124/
https://www.ncbi.nlm.nih.gov/pubmed/17325709
http://dx.doi.org/10.1038/sj.bjc.6603505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360124/
https://www.ncbi.nlm.nih.gov/pubmed/17325709
http://dx.doi.org/10.1038/sj.bjc.6603505

Ejemplares similares